Chapter 16: A Brief Appraisal of Nanomaterials for COVID-19
-
Published:25 Mar 2024
-
Special Collection: 2024 eBook Collection
I. Chakraborty, I. Govindaraju, N. Pooja, R. Biswas, and N. Mazumder, in Smart Nanomaterials for Infectious Diseases, ed. S. Kanchi, N. Sharotri, R. Chokkareddy, D. Sharma, and F. H. Hussein, Royal Society of Chemistry, 2024, vol. 62, ch. 16, pp. 378-386.
Download citation file:
Novel technology was needed to develop preventive and therapeutic methods against the severe acute respiratory syndrome (SARS)-caused coronavirus 2019 (COVID-19), and the recent pandemic accelerated the development of nanotechnology for SARS-CoV-2 virus detection, treatment, and prevention. Safe and effective COVID-19 vaccines that elicit long-lasting immunity in the human system were required, and also the development of effective detection tools, medications, treatments, and preventive measures. The effectiveness of nanoparticles in battling COVID-19 is highlighted in this chapter.